Delhi Summit 2007 - Scientific Program - Session III

Chairs:
Dr. R. Hull, Director of Thrombosis Research Unit, and Professor of University of Calgary, Canada
Dr. A. Arora, Consultant, Hyperlipidemia Prevention & Atherosclerosis Clinic, Dept. of Cardiology, Sir Ganga Ram Hospital, New Delhi, India

Moderator:
Rakesh Wahi, M.D., Consultant, Loyola University Medical Center
Angelos Halaris, M.D., Loyola University Medical Center

02:30 - 02:50 PM Clinical Indications & Evidence for Individual Low Molecular Weight Heparins
R. Hull, Professor of University of Calgary, Canada
02:50 - 03:10 PM Anticoagulation in Cardiology: Are Guidelines Needed for Low Molecular Weight Heparins?
N. Kipschidze, Professor at Columbia University, New York, USA
Director of Lenox Hill Heart & Vascular Institute
03:10 - 03:30 PM Anticoagulation in Surgery: Are Guidelines Needed for Low Molecular Weight Heparins? IUA Position.
E. Kalodiki, Imperial College of College of Science, Technology and Medicine, London, England
03:30 - 03:50 PM Anticoagulation for Medical & Cancer Patients: Are Guidelines Needed for Low Molecular Weight Heparins?
R. Saxena-R. Yadav Professors, All India Institute of Medical Sciences, New Delhi, India
03:50 - 04:10 PM Update of Heparin Induced Thrombocytopenia
J. Walenga, Professor Loyola University Medical Center, USA
R. Hull, Professor of University of Calgary, Canada
04:10 - 04:30 PM Participants Input
Question, Answer & Panel Discussion Period
04:30 - 04:50 PM Coffee Break

 

Back to Scientific Program Overview